Global Immunodeficiency Therapeutics Market By Therapy Type (Gene Therapy, Immunoglobulin Replacement Therapy, Antibiotics Therapy, Stem Cell Transplantation, Others); Route of Administration (Intravenous, Subcutaneous); By Disorder Type (Primary – Common Variable Immunodeficiency (CVID), Severe Combined Immunodeficiency (SCID) (Alymphocytosis), Chronic Granulomatous Disease (CGD), Others, Secondary – AIDS, Cancer, Hepatitis, Others); By Demography (Kids, Adults); By Test Type (Blood Prenatal); By End Users (Hospitals and Clinics, Specialized Clinics, Research Centers, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030